A public interest suit has been filed against the directors of pharmaceuticals major Ranbaxy Laboratories for allegedly manufacturing adulterated drugs, Business Standard reported.
The petition filed in the Supreme Court sought prosecution of all current and former directors of the company. Manohar Lal Sharma, the petitioner, also sought sealing of the company’s manufacturing facilities at Paonta Sahib and Devas in Madhya Pradesh. Sharma has mentioned the Central Bureau of Investigation (CBI) as one of the respondents in the case.
A Ranbaxy spokesperson said the company didn’t receive any official communication on this and, therefore, it wasn’t in a position to comment.
Read the full report here